Trillium Therapeutics Corp.'s ticker is SCTPF and the CUSIP is 89620X100. A total of 1 filers reported holding Trillium Therapeutics Corp. in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $2,782,000 | -1.1% | 11,664,286 | +2900.0% | 0.54% | -1.8% |
| Q4 2017 | $2,813,000 | -37.7% | 388,810 | -46.8% | 0.55% | +29.4% |
| Q1 2017 | $4,512,000 | +118.6% | 730,654 | +100.0% | 0.42% | +4.2% |
| Q4 2016 | $2,064,000 | -33.2% | 365,327 | +74.6% | 0.40% | -28.6% |
| Q3 2016 | $3,092,000 | +64.6% | 209,177 | 0.0% | 0.57% | +41.4% |
| Q2 2016 | $1,878,000 | -15.2% | 209,177 | -12.7% | 0.40% | -13.8% |
| Q1 2016 | $2,215,000 | -15.1% | 239,477 | +15.7% | 0.46% | -9.4% |
| Q4 2015 | $2,609,000 | -3.2% | 206,937 | 0.0% | 0.51% | -1.7% |
| Q3 2015 | $2,696,000 | -83.3% | 206,937 | -98.3% | 0.52% | -77.2% |
| Q2 2015 | $16,156,000 | +7.7% | 12,033,160 | -0.0% | 2.29% | +10.7% |
| Q1 2015 | $14,994,000 | +113.3% | 12,038,159 | -0.3% | 2.07% | +116.2% |
| Q4 2014 | $7,030,000 | – | 12,069,127 | – | 0.96% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AWM Investment Company, Inc. | 206,937 | $2,696,000 | 0.52% |